Clinical characteristics of dry mouth in overactive bladder patients treated with antimuscarnics and mirabegron

Trial Profile

Clinical characteristics of dry mouth in overactive bladder patients treated with antimuscarnics and mirabegron

Completed
Phase of Trial: Phase IV

Latest Information Update: 26 Oct 2016

At a glance

  • Drugs Mirabegron (Primary) ; Fesoterodine; Imidafenacin; Propiverine; Solifenacin
  • Indications Overactive bladder
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 26 Oct 2016 New trial record
    • 16 Sep 2016 Results presented at the 46th Annual Meeting of the International Continence Society
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top